Iridex (IRIX) Amortizatization of Intangibles (2024 - 2025)

Iridex's (IRIX) quarterly Amortizatization of Intangibles came in at -$58000.0 in Q1 2025, up 33.33% quarter-over-quarter from -$87000.0 in Q4 2024.

Iridex (IRIX) Amortizatization of Intangibles (2024 - 2025) Analysis & Trends

Iridex's Amortizatization of Intangibles history runs 2 years deep, the most recent figure standing at -$58000.0 for Q1 2025.

On a quarterly basis, Amortizatization of Intangibles changed N/A year-over-year to -$58000.0 in Q1 2025; TTM through Jan 2026 was -$58000.0, a 60.27% increase from a year earlier, with the FY2026 full-year figure at -$58000.0, up 60.27% from the prior year.
Amortizatization of Intangibles advanced to -$58000.0 in Q1 2025 per IRIX's latest filing, from -$87000.0 in the prior quarter.
Across five years, Amortizatization of Intangibles topped out at -$58000.0 in Q1 2025 and bottomed at -$87000.0 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Amortizatization of Intangibles (Qtr)
1	Abbott Laboratories	182.32 Bn	175.02 Bn	6.27 Bn	-
2	Stryker	128.75 Bn	125.88 Bn	3.81 Bn	-
3	Medtronic	107.83 Bn	98.61 Bn	6.41 Bn	-
4	Boston Scientific	67.61 Bn	66.15 Bn	3.61 Bn	-
5	Edwards Lifesciences	48.13 Bn	44.45 Bn	1.29 Bn	-
6	Dexcom	28.26 Bn	27.14 Bn	750.30 Mn	-
7	GE HealthCare Technologies	27.78 Bn	25.50 Bn	1.98 Bn	-
8	Smith & Nephew	26.99 Bn	26.41 Bn	-	-
9	Koninklijke Philips	23.92 Bn	20.80 Bn	2.07 Bn	-
10	Iridex	15.41 Mn	10.81 Mn	4.74 Mn	-

Download Data